Fountain Healthcare Partners β Full Portfolio
29 tracked investments Β· listed companies and verified rows first
XyloCor Therapeutics develops gene therapies for advanced coronary artery disease and cardiac damage.
BiotechHealthtechMedical DevicesMalvern, US
Ronald Crystal(Co-founder)Todd Rosengart(Co-founder)John Tucker(President and Chief Executive Officer)Albert Gianchetti(Executive Officer, Director)
BoardGlenn Batchelder(Director)James Cohen(Director)
Co-investorsLumira VenturesJeito CapitalLongwood FundSofinnova Ventures
Co-investorsRed River West
Amarin Corporation is a cardiovascular health pharmaceutical company developing treatments to prevent cardiovascular disease.
BiotechHealthtechMedical Devices
Co-investorsAvoro Capital AdvisorsLongitude CapitalSignet Healthcare PartnersSofinnova Ventures
Aneta operates an email-based AI research service that runs 15 specialized agents across academic, market, technical, and legal sources for days to produce long, citation-backed research reports.
AI & Machine LearningEnterprise SoftwareSaaS
Co-investorsPebblebedAndera PartnersBGVForbionHTGFPMV+2 more
Co-investorsM Ventures
HealthtechHayward, US
GUY DIPIERRO(Director)ALAN LEVY, PH.D.(Executive Officer, Director)ANTHONY RIMAC(Executive Officer)ALAN LEVY(Executive Officer, Director)
BoardELIZABETH ROCKETT(Director)WENDE HUTTON(Director)in
Co-investorsEmergent Medical Partners, LLPKaiser Permanente VenturesMission Bay CapitalCanaan Partners
Corteria Pharmaceuticals develops first-in-class drugs for conditions with high unmet medical need, including worsening and acute decompensated heart failure, right heart failure, sarcopenia, and obesity with complications.
BiotechHealthtech
Co-investorsInvivo Capital PartnersJeito CapitalKurma PartnersLifeArc VenturesOrbiMedV-Bio Ventures
Co-investorsAndera PartnersPMV
EXCIVA is a privately held biotech company developing clinical-stage therapeutics for neuropsychiatric indications, with a focus on treating neuropsychiatric symptoms of dementia such as agitation and aggression in Alzheimer's disease.
BiotechDigital HealthLongevityHeidelberg, DE
Co-investorsAndera PartnersLifeArc VenturesModi Ventures
Co-investorsLongitude Capital
Co-investorsSofinnova Ventures
AdmitHub provides AI-powered success coaching and conversation tools for higher education institutions to improve student engagement, retention, and outcomes.
AI & Machine LearningEdTechHR TechArlington, US
Andrew Magliozzi(Founder)in
Co-investorsFundersClubMichelson 20MM FoundationNXT VenturesTechstarsAlly Bridge GroupGilde Healthcare+3 more
HealthtechPlymouth, US
Dan Sachs(Director)Peter Crosby(Executive Officer, Director)Jason Hannonin
BoardManus Rogan(Director)Antoine Papiernik(Director)
Co-investorsSofinnova PartnersAlly Bridge GroupGilde HealthcareViking Global Investors
MMI develops the Symani Surgical System, a robotic platform with NanoWrist instruments designed for microsurgery and supermicrosurgery, enabling surgeons to perform delicate procedures such as dissection and anastomosis.
HealthtechMedical DevicesRoboticsJacksonville, US
Mark Toland(Executive Officer, Director)Andrew Cleeland(Director)Justin Lynch(Director)Theresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)
Co-investorsAndera PartnersCorewell Health VenturesDeerfield Management Company
Co-investorsAdvent Life SciencesOrbiMedColumbus Venture Partners
Neurent Medical develops the NEUROMARK System, a minimally invasive radiofrequency ablation device that disrupts overactive posterior nasal nerves to treat chronic rhinitis.
HealthtechMedical Devices
Co-investorsAtlantic Bridge VenturesEnterprise IrelandEQT Life SciencesWestern Development Commission
Neurent Medical develops the NEUROMARK System, a minimally invasive radiofrequency ablation device used in ENT surgery to disrupt overactive posterior nasal nerves and treat chronic rhinitis.
HardwareHealthtechMedical Devices
Co-investorsAtlantic Bridge Ventures
Neuromod is a medical technology company that developed Lenire, an FDA-approved bimodal neuromodulation device for treating tinnitus.
HardwareHealthtechMedical Devices
Priothera is a clinical-stage biopharmaceutical company developing mocravimod, an investigational immune modulator intended as a maintenance therapy for allogeneic hematopoietic cell transplantation.
BiotechHealthtech
Florent Gros(Founder & CEO)
Co-investors4see VenturesHealthCap
Spark Therapeutics, now part of the Roche Group, focuses on delivering therapies to improve patient outcomes and create healthier communities.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsSofinnova Ventures
AbbVie is a pharmaceutical company that discovers and develops medicines, working with external innovation partners to conduct research.
BiotechHealthtech
Co-investorsArtis VenturesNew Enterprise Associates (NEA)Fidelity InvestmentsFounders Fund
Vivasure Medical develops PerQseal Elite, a fully bio-absorbable, sutureless patch-based vascular closure system for large-bore arterial and venous access in cardiovascular and endovascular procedures.
HealthtechMedical Devices
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.